X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6637) 6637
Newspaper Article (2904) 2904
Publication (716) 716
Web Resource (150) 150
Trade Publication Article (141) 141
Book Review (90) 90
Magazine Article (77) 77
Book Chapter (56) 56
Conference Proceeding (15) 15
Book / eBook (10) 10
Dissertation (9) 9
Government Document (5) 5
Transcript (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
endocrine therapy (8803) 8803
breast cancer (5372) 5372
oncology (4134) 4134
humans (4064) 4064
female (3259) 3259
index medicus (3055) 3055
cancer therapies (2241) 2241
chemotherapy (2109) 2109
breast neoplasms - drug therapy (2095) 2095
cancer (1883) 1883
tamoxifen (1765) 1765
womens health (1724) 1724
middle aged (1654) 1654
metastasis (1473) 1473
aged (1457) 1457
postmenopausal women (1365) 1365
breast neoplasms - pathology (1337) 1337
care and treatment (1225) 1225
estrogen (1160) 1160
patients (1118) 1118
adult (1037) 1037
research (1031) 1031
tumors (1028) 1028
antineoplastic agents, hormonal - therapeutic use (945) 945
women (914) 914
breast neoplasms - metabolism (901) 901
prognosis (901) 901
surgery (881) 881
health aspects (858) 858
clinical trials (825) 825
prostate cancer (823) 823
studies (788) 788
medicine & public health (762) 762
aromatase inhibitors (718) 718
medical research (714) 714
gene expression (706) 706
treatment outcome (698) 698
analysis (694) 694
aged, 80 and over (677) 677
male (656) 656
tamoxifen - therapeutic use (648) 648
estrogen-receptor (606) 606
receptors, estrogen - metabolism (599) 599
survival (589) 589
breast neoplasms - genetics (588) 588
adjuvant endocrine therapy (579) 579
medical prognosis (569) 569
randomized-trial (562) 562
expression (559) 559
chemotherapy, adjuvant (552) 552
transgender persons (548) 548
anastrozole (539) 539
hormones (532) 532
letrozole (501) 501
aromatase inhibitors - therapeutic use (487) 487
radiation therapy (486) 486
therapy (485) 485
medicine (481) 481
menopause (475) 475
breast neoplasms - mortality (469) 469
drug therapy (457) 457
risk factors (443) 443
neoplasm staging (437) 437
double-blind (436) 436
immunohistochemistry (428) 428
animals (423) 423
adjuvant treatment (420) 420
postmenopause (414) 414
carcinoma (406) 406
epidermal growth factor (399) 399
disease-free survival (398) 398
antineoplastic combined chemotherapy protocols - therapeutic use (393) 393
estrogen receptor (373) 373
article (372) 372
oncology, experimental (372) 372
breast (371) 371
antineoplastic agents - therapeutic use (367) 367
fulvestrant (364) 364
quality of life (354) 354
health risk assessment (351) 351
genetic aspects (348) 348
retrospective studies (343) 343
proteins (339) 339
hematology, oncology and palliative medicine (336) 336
mortality (334) 334
trial (334) 334
breast neoplasms - therapy (332) 332
kinases (326) 326
research article (322) 322
cell line, tumor (321) 321
fda approval (320) 320
obstetrics & gynecology (319) 319
biomarkers (318) 318
cell cycle (317) 317
survival analysis (316) 316
gender identity (314) 314
aromatase inhibitor (309) 309
skin and connective tissue diseases (307) 307
endocrinology & metabolism (304) 304
receptors, progesterone - metabolism (304) 304
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9534) 9534
Japanese (198) 198
German (100) 100
French (61) 61
Chinese (34) 34
Polish (11) 11
Spanish (10) 10
Russian (9) 9
Hungarian (6) 6
Korean (5) 5
Turkish (5) 5
Italian (3) 3
Czech (1) 1
Portuguese (1) 1
Serbian (1) 1
Swedish (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 24, pp. 2465 - 2472
PurposeThis phase III study evaluated ribociclib plus fulvestrant in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative... 
TRIAL | DOUBLE-BLIND | PALBOCICLIB | ENDOCRINE THERAPY | ONCOLOGY | TUMORS
Journal Article
Diabetic Medicine, ISSN 0742-3071, 03/2019, Volume 36, Issue S1, pp. 134 - 135
Journal Article
LANCET ONCOLOGY, ISSN 1470-2045, 11/2011, Volume 12, Issue 12, pp. 1101 - 1108
Background Postmenopausal women with hormone receptor-positive early breast cancer have persistent, long-term risk of breast-cancer recurrence and death.... 
DOUBLE-BLIND | COMPARING LETROZOLE | ONCOLOGY | ADJUVANT ENDOCRINE THERAPY | PHASE-III
Journal Article
Behavioral Neuroscience, ISSN 0735-7044, 08/2018, Volume 132, Issue 4, p. 224
Human affective life changes with age, becoming more positive and less negative in later life. This change occurs even as aging leads to declines in health and... 
Menopause | Estrogen | Aging | Endocrine therapy
Journal Article
Clinical Chemistry, ISSN 0009-9147, 11/2017, Volume 63, Issue 11, pp. 1684 - 1684
[...]calculating glomerular filtration rate (GFR)2 for a transgender male receiving testosterone on the basis of male categorization may lead to overestimation... 
Ethnicity | Laboratories | Endocrine therapy | Transgender persons
Journal Article
Journal of pediatric endocrinology & metabolism : JPEM, ISSN 0334-018X, 08/2019, Volume 32, Issue 10, pp. 1049 - 1053
Background This study aimed to determine cardiac findings in patients with mucopolysaccharidosis (MPS) and to assess the changes in these findings after enzyme... 
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 01/2017, Volume 35, Issue 2, pp. 261 - 261
Journal Article
The Lancet Oncology, ISSN 1470-2045, 11/2019, Volume 20, Issue 11, pp. e617 - e617
Journal Article
CLINICAL ONCOLOGY, ISSN 0936-6555, 09/2016, Volume 28, Issue 9, pp. 612 - 613
Journal Article
LANCET, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, pp. 1134 - 1150
Breast cancer is one of the three most common cancers worldwide. Early breast cancer is considered potentially curable. Therapy has progressed substantially... 
PHASE-III TRIAL | ZOLEDRONIC ACID | MEDICINE, GENERAL & INTERNAL | NEOADJUVANT CHEMOTHERAPY | ADJUVANT ENDOCRINE THERAPY | LYMPH-NODE SURGERY | TERM-FOLLOW-UP | OPEN-LABEL | PACLITAXEL PLUS TRASTUZUMAB | POSTMENOPAUSAL WOMEN | INTERNATIONAL CONSENSUS GUIDELINES
Journal Article
Annals of Oncology, ISSN 0923-7534, 12/2018, Volume 29, Issue 12, pp. 2274 - 2278
Journal Article
Cancer Research, ISSN 0008-5472, 09/2002, Volume 62, Issue 17, pp. 4849 - 4853
Estrogen receptor (ER) betacx, a splice variant of ERbeta, is a dominant repressor of ERalpha function. In this study we investigated the possibility that... 
ENDOCRINE THERAPY | ONCOLOGY | CLONING | TAMOXIFEN
Journal Article
BMC Cancer, ISSN 1471-2407, 12/2019, Volume 19, Issue 1, pp. 1 - 12
Abstract Background Despite much effort on the treatment of breast cancer over the decades, a great uncertainty regarding the appropriate molecular biomarkers... 
Endocrine therapy | Chemotherapy | Breast cancer | Prognosis | SPAG5
Journal Article
The American Journal of Clinical Nutrition, ISSN 0002-9165, 09/2015, Volume 102, Issue 3, p. 680
  Hormone therapy has been shown to increase risk of ischemic stroke in women. Plant-derived estrogens, particularly soy isoflavones, are known to have some... 
Stroke | Diet | Risk assessment | Estrogen | Endocrine therapy
Journal Article
Annals of Nutrition & Metabolism, ISSN 0250-6807, 01/2018, Volume 72, p. 1
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2009, Volume 27, Issue 21, pp. 3423 - 3429
Purpose Recently, a 36-kDa variant of estrogen receptor alpha (ER-alpha 66), ER-alpha 36, has been identified and cloned. ER-alpha 36 predominantly localizes... 
CELLS | ONCOGENE | ASSAY | ONCOLOGY | GROWTH | ENDOCRINE THERAPY | MECHANISMS | ASSOCIATION | HER-2 | STRATEGIES
Journal Article
ISSN 0960-0760, 2016
While estrogens have been shown to modulate EGFR/HER-1 and HER-2/neu expression in experimental systems, the effects of estrogen deprivation on expression... 
breast cancer | neuregulin-1 | ErbB | endocrine therapy
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 03/2019, Volume 37, Issue 8, pp. 636 - 636
PURPOSETamoxifen is widely prescribed as adjuvant therapy in patients with early-stage breast cancer. It has been postulated that concentrations of endoxifen,... 
DOSE-ESCALATION | WOMEN | POLYMORPHISMS | METAANALYSIS | ENDOXIFEN | ONCOLOGY | BREAST-CANCER PATIENTS | ENDOCRINE THERAPY | RECEPTOR | RECURRENCE | CYP2D6 GENOTYPE
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.